ASCO® 2024 Summary: "Experts Discuss Key Studies in HCC and BTC"

2024 ASCO® Annual Meeting Insights Hub

R. Kim, T. Biachi

ASCO® 2024 Summary: "Expert Panel Discussion on Hepatobiliary Cancer…

2024 ASCO® Annual Meeting Insights Hub

N. Uboha, K. Spencer, M. Cecchini

ASCO GI 2023 Characterization of Long-Term Survivors in the TOPAZ-1 …

ASCO GI 2023 Conference Coverage

M. Bouattour

Selecting Patients Wisely for Neoadjuvant Therapy in Pancreatic and …

ecancer

S. Shrikhande

OncoAlert Top FDA Approvals for Solid Cancers in 2022

OncoAlert

G. Morgan

ESMO 2022 on the Updated OS From the Phase 3 TOPAZ-1 Study: Durvalum…

ESMO 2022 Conference Coverage

D. Oh

Targeted Therapies for Cholangiocarcinoma

Lorenza Rimassa

ASCO 2021 Q&A Discussion on GI Cancers: New Findings and Data Overvi…

2021 ASCO Virtual Direct™ Highlights

D. Lin, A. Loaiza-Bonilla

Immunotherapy for Cholangiocarcinoma

Nicola Personeni

Chemotherapy for Cholangiocarcinoma

Lorenza Rimassa

Lecture Summary - Immunotherapy for Cholangiocarcinoma

Nicola Personeni

Lecture Summary - Chemotherapy for Cholangiocarcinoma

Lorenza Rimassa

Lecture Summary - Targeted Therapies for Cholangiocarcinoma

Lorenza Rimassa

2021 ASCO Highlights on GI Cancers: Discussing the New Data and the …

2021 ASCO Virtual Direct™ Highlights

S. Jain, H. Soares

New Frontiers of PARPi Therapy in Pancreatic and Biliary Cancers: Tu…

GOG Foundation

J. Abbruzzese

2021 ASCO Summary on Non-colorectal Cancers: ESCC, Esophageal/GEJ, &…

2021 ASCO Virtual Direct™ Highlights

K. Wong

2021 ASCO Highlights: Surveying the Clinical Data for Non-colorectal…

2021 ASCO Virtual Direct™ Highlights

H. Soares

2021 ASCO Non-CRC Summary: Overview of GE, Hepatobiliary & Pancreati…

2021 ASCO Virtual Direct™ Highlights

L. Abushahin

ASCO 2021 Q&A Discussion on GI Cancers: Overview of Recent Trials an…

2021 ASCO Virtual Direct™ Highlights

S. Klempner, L. Connell

ASCO 2021 Panel Discussion: Data Review on GI Cancers

2021 ASCO Virtual Direct™ Highlights

J. Hays, L. Abushahin